EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 25 (Mars 2009) Hors Série n° 1 Med Sci (Paris), 25 (2009) 29-32 References
Free Access
Issue
Med Sci (Paris)
Volume 25, Mars 2009
Évaluation des risques et perspectives thérapeutiques en oncologie colorectale
Page(s) 29 - 32
Section La place du ciblage thérapeutique
DOI https://doi.org/10.1051/medsci/2009251s29
Published online 15 January 2009
  1. Boman BM, Huang E. Human colon cancer stem cells: a new paradigm in gastrointestinal oncology. J Clin Oncol 2008; 26 : 2828–38. [Google Scholar]
  2. Scoville DH, Sato T, He XC, Li L. Current view: intestinal stem cells and signaling. Gastroenterology 2008; 134 : 849–64. [Google Scholar]
  3. Sääf AM, Halbleib JM, Chen X, et al. Parallels between global transcriptional programs of polarizing Caco-2 intestinal epithelial cells in vitro and gene expression programs in normal colon and colon cancer. Mol Biol Cell 2007; 18 : 4245–60. [Google Scholar]
  4. Van den Brink GR, Offerhaus GJ. The morphogenetic code and colon cancer development. Cancer Cell 2007; 11 : 109–17. [Google Scholar]
  5. Fodde R. The multiple functions of tumour suppressors: it’s all in APC. Nat Cell Biol 2003; 5 : 190–2. [Google Scholar]
  6. Buckowitz A, Knaebel HP, Benner A, et al. Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases. Br J Cancer 2005; 92 : 1746–53. [Google Scholar]
  7. Zeitoun G, Buecher B, Bayer J, et al. Retention of chromosome arm 5q in stage II colon cancers identifies 83 % of liver metastasis occurrences. Genes Chrom Cancer 2006; 45 : 94–102. [Google Scholar]
  8. Albuquerque C, Breukel C, Van der Luijt R, et al. The just-right signalling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signalling cascade. Hum Mol Genet 2002; 11 : 1549–60. [Google Scholar]
  9. Suzuki H, Masuda N, Shimura T, et al. Nuclear beta-catenin expression at the invasive front and in the vessels predicts liver metastasis in colorectal carcinoma. Anticancer Res 2008; 28 : 1821–30. [Google Scholar]
  10. Prochownik EV. c-Myc: linking transformation and genomic instability. Curr Mol Med 2008; 8 : 446–58. [Google Scholar]
  11. Al-Mulla F, AlFadhli S, Al-Hakim AH, et al. Metastatic recurrence of early-stage colorectal cancer is linked to loss of heterozygosity on chromosomes 4 and 14q. J Clin Pathol 2006; 59 : 624–30. [Google Scholar]
  12. Tassi E, Wellstein A. The angiogenic switch molecule, secreted FGF-binding protein, an indicator of early stages of pancreatic and colorectal adenocarcinoma. Semin Oncol 2006; 33 (suppl 11) : S50–6. [Google Scholar]
  13. Mourra N, Zeitoun G, Portier G, et al. High-resolution genotyping of chromosome 8 in colon adenocarcinomas reveals recurrent break point but no gene mutation in the 8p21 region. Diagn Mol Pathol 2008; 17 : 90–3. [Google Scholar]
  14. Brocardo M, Lei Y, Tighe A, et al. Mitochondrial targeting of adenomatous polyposis coli protein is stimulated by truncating cancer mutations: regulation of Bcl-2 and implications for cell survival. J Biol Chem 2008; 283 : 5950–9. [Google Scholar]
  15. Horak CE, Steeg PS. Metastasis gets site specific. Cancer Cell 2005; 8 : 93–5. [Google Scholar]
  16. Dimberg J, Hugander A, Löfgren S, Wågsäter D. Polymorphism and circulating levels of the chemokine CXCL12 in colorectal cancer patients. Int J Mol Med 2007; 19 : 11–5. [Google Scholar]
  17. Zeitoun G, Mourra N, Blanche-Koch H, Thomas G, Olschwang S. Genomic profile of colon cancer metastases. Anticancer Res 2008; 28 : 3609–12. [Google Scholar]
  18. Pardali K, Moustakas A. Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. Biochim Biophys Acta 2007; 1775 : 21–62. [Google Scholar]
  19. Lash GE, Otun HA, Innes BA, et al. Inhibition of trophoblast cell invasion by TGFB1, 2, and 3 is associated with a decrease in active proteases. Biol Reprod 2005; 73 : 374–81. [Google Scholar]
  20. Allgayer H, Aguirre-Ghiso JA. The urokinase receptor (u-PAR): a link between tumor cell dormancy and minimal residual disease in bone marrow ? APMIS 2008; 116 : 602–14. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.